A Problem Growing in the Shadows
While many public health conversations focus on dramatic outbreaks and emerging viruses, one of the most significant long-term health threats advances quietly: antimicrobial resistance (AMR). Sometimes called antibiotic resistance (though the problem extends to antifungals and antivirals too), AMR occurs when microorganisms — bacteria, viruses, fungi, and parasites — evolve to withstand the drugs designed to kill them.
The result is that infections that were once straightforward to treat become difficult, prolonged, or impossible to cure. Routine surgeries, cancer chemotherapy, and organ transplants all depend on effective antibiotics to prevent and treat infections. When those drugs stop working, the risks multiply across the entire healthcare system.
How Resistance Develops
Resistance is a natural evolutionary process. When bacteria are exposed to an antibiotic, most die — but any that carry a genetic variation that helps them survive will reproduce, passing on that resistance. The problem is dramatically accelerated by human behaviour:
- Overuse in human medicine: Antibiotics prescribed unnecessarily (for viral infections like the flu, which they cannot treat) give bacteria repeated opportunities to develop resistance without therapeutic benefit.
- Incomplete courses: Stopping antibiotics early can allow partially resistant bacteria to survive and multiply.
- Agricultural use: Large quantities of antibiotics are used in livestock farming, both to treat illness and, historically, to promote growth. This creates reservoirs of resistant bacteria that can spread to humans.
- Inadequate sanitation: Poor water and sanitation infrastructure allows resistant bacteria to spread more easily through communities.
Which Infections Are Affected?
AMR is already affecting a wide range of common conditions:
- Urinary tract infections caused by resistant E. coli
- Tuberculosis (drug-resistant TB is a major global health challenge)
- Gonorrhoea (strains resistant to multiple antibiotics have emerged)
- Bloodstream infections (sepsis) caused by resistant bacteria
- Pneumonia caused by resistant Staphylococcus aureus (MRSA)
The Global Picture
AMR disproportionately affects lower-income countries, where access to quality antibiotics is inconsistent, diagnostics are limited, and sanitation infrastructure is less robust. At the same time, the problem is inherently global — resistant bacteria travel with people, animals, and food across borders, meaning no country can solve it in isolation.
International health organisations, including the World Health Organization, have identified AMR as one of the major threats to global health and called for coordinated international action on surveillance, research, and the responsible use of antimicrobials.
What Individuals Can Do
- Only take antibiotics when prescribed by a qualified healthcare professional for a confirmed bacterial infection.
- Complete the full course of any prescribed antibiotic, even if you feel better before it is finished.
- Never share antibiotics or use leftover prescriptions from previous illnesses.
- Practice good hygiene — handwashing, food safety, and vaccination reduce infections and the need for antibiotics in the first place.
- Ask questions — if a doctor prescribes antibiotics, it is reasonable to ask whether they are truly necessary.
What Governments and Industry Must Do
Individual behaviour alone is insufficient. Addressing AMR also requires systemic action: stronger regulation of antibiotic use in agriculture, increased investment in the development of new antimicrobials (a pipeline that has been thin for decades), improved global surveillance of resistance patterns, and better access to diagnostics so that appropriate treatments can be identified quickly.
AMR may not make front pages as often as a pandemic, but its steady advance poses a profound threat to modern medicine. Understanding it is the first step toward the collective response it demands.